\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ recent\\ physical\\ exam\\ on\\ record\ \(0\)\
\-\ 24jun2004\\:\\ biopsy\\ of\\ esophagus\\ \\â\\€\\“\\ no\\ metaplasia\\ present\ \(0\)\
\-\ 25june2005\\:\\ all\\ values\\ of\\ basic\\ metabolic\\ panel\\ are\\ within\\ normal\\ limits\ \(0\)\
\-\ patient\\ has\\ had\\ stable\\ postoperative\\ films\\ since\\ 2001\\.\\ continue\\ with\\ annual\\ biopsies\\ and\\ ct\\ and\\ plain\\ films\\ twice\\ a\\ year\\ for\\ at\\ least\\ five\\ years\\.\ \(0\)\
\-\ chest\\ pa\\:\\ descending\\ aorta\\ shadow\\ obscured\\ by\\ retrocardiac\\ opacity\\.\\ \ \(0\)\
\-\ chest\\ lat\\:\\ abnormal\\ soft\\ tissue\\ density\\ in\\ a\\ retrocardiac\\ position\\ obscuring\\ the\\ posterior\\ border\\ of\\ left\\ ventricle\\.\\ \\ \ \(0\)\
\-\ ct\\:\\ dilated\\ esophagus\\ with\\ air\\ contrast\\ level\\ extending\\ from\\ the\\ thoracic\\ inlet\\ to\\ the\\ diaphragm\\.\\ lower\\ images\\ show\\ surgical\\ clips\\.\ \(0\)\
\-\ gastric\\ pull\\ through\ \(2\)\
\-\ \\(lower\\ middle\\ mediastinal\\ mass\\)\ \(0\)\
\-\ esophageal\\ processes\\:\\ achalasia\\,\\ esophageal\\ mass\\ \\(leiomyoma\\)\\,\\ hiatal\\ hernia\\,\\ or\\ gastric\\ pull\\ through\ \(0\)\
\-\ tracheal\\ or\\ esophageal\\ duplication\\ cysts\ \(0\)\
\-\ aortic\\ ectasia\\ or\\ aneurysm\ \(0\)\
\-\ 46\\-year\\-old\\ caucasian\\ male\\ with\\ a\\ history\\ of\\ squamous\\ cell\\ carcinoma\\ of\\ the\\ middle\\ third\\ of\\ the\\ esophagus\\ in\\ 2001\\.\\ pt\\ is\\ s\\/p\\ transhiatal\\ esophagectomy\\ and\\ chemoradiation\\ and\\ neoadjuvant\\ chemotherapy\\.\\ here\\ for\\ follow\\-up\\ and\\ screening\\ for\\ recurrence\\.\ \(0\)\
\-\ malignant\\ epithelial\\ tumors\\ of\\ the\\ esophagus\\ are\\ almost\\ always\\ primary\\ carcinomas\\.\\ worldwide\\,\\ squamous\\ cell\\ carcinoma\\ \\(scca\\)\\ is\\ the\\ most\\ common\\ type\\ and\\ ranks\\ fifth\\ in\\ mortality\\ rate\\ among\\ tumor\\ sites\\.\\ genetic\\ predisposition\\,\\ dietary\\ habits\\,\\ environmental\\ exposures\\,\\ and\\ alcohol\\ and\\ tobacco\\ use\\ have\\ all\\ been\\ implicated\\ as\\ causative\\ factors\\ for\\ the\\ disease\\.\\ 1\ \(0\)\
\-\ clinically\\,\\ patients\\ with\\ esophageal\\ cancer\\ present\\ with\\ dysphagia\\ \\(90\\%\\)\\ and\\/or\\ odynophagia\\ \\(50\\%\\)\\.\\ by\\ the\\ time\\ they\\ seek\\ treatment\\ upwards\\ of\\ 75\\%\\ have\\ experienced\\ anorexia\\ and\\ weight\\ loss\\ and\\ report\\ considerably\\ altered\\ diets\\ due\\ to\\ luminal\\ compromise\\.\\ generally\\ there\\ are\\ no\\ specific\\ physical\\ findings\\ with\\ scca\\.\\ patients\\ with\\ symptoms\\ of\\ esophageal\\ cancer\\ are\\ often\\ worked\\ up\\ in\\ the\\ following\\ manner\\.\\ pa\\ and\\ lateral\\ chest\\ radiographs\\ are\\ obtained\\ in\\ those\\ with\\ chronic\\ cough\\ or\\ abnormal\\ findings\\ on\\ chest\\ auscultation\\ to\\ demonstrate\\ metastases\\ or\\ infiltrates\\ suggestive\\ of\\ aspiration\\ or\\ esophagorespiratory\\ fistula\\.\\ \\ findings\\ may\\ include\\ lateral\\ deviation\\ of\\ the\\ mediastinal\\ contents\\,\\ widening\\ of\\ the\\ mediastinum\\,\\ and\\ esophageal\\ air\\-fluid\\ levels\\.\\ contrast\\ esophagography\\ using\\ barium\\ is\\ usually\\ indicated\\ to\\ rule\\ out\\ other\\ disorders\\ with\\ similar\\ presentations\\ such\\ as\\ achalasia\\.\\ barium\\ swallows\\ in\\ patients\\ with\\ scaa\\ can\\ demonstrate\\ high\\-grade\\ stenosis\\,\\ complete\\ obstruction\\,\\ and\\ fistulas\\.\\ flexible\\ endoscopy\\ is\\ also\\ generally\\ indicated\\ since\\ it\\ allows\\ direct\\ visualization\\ of\\ the\\ esophagus\\ as\\ well\\ as\\ the\\ opportunity\\ to\\ obtain\\ tissue\\ samples\\.\\ obtaining\\ at\\ least\\ six\\ biopsy\\ samples\\ yields\\ a\\ diagnosis\\ with\\ an\\ accuracy\\ approaching\\ 100\\%\\.\\ endoscopy\\ aids\\ in\\ accurate\\ characterization\\ of\\ the\\ tumor\\â\\€\\™s\\ configuration\\,\\ length\\,\\ and\\ localization\\.\\ it\\ also\\ aids\\ in\\ initial\\ relief\\ of\\ dysphagia\\ because\\ dilation\\ can\\ be\\ performed\\ at\\ the\\ same\\ time\\.\\ 1\ \(0\)\
\-\ esophageal\\ cancer\\ is\\ considered\\ a\\ treatable\\ disease\\,\\ but\\ one\\ that\\ is\\ rarely\\ curable\\.\\ the\\ overall\\ five\\-year\\ survival\\ rate\\ in\\ patients\\ that\\ are\\ amenable\\ to\\ surgery\\ ranges\\ from\\ 5\\-20\\%\\.\\ radiation\\ or\\ chemoradiotherapy\\ alone\\ are\\ considered\\ suboptimal\\ primary\\ treatment\\ modalities\\ because\\ of\\ locally\\ persistent\\ or\\ recurrent\\ disease\\.\\ current\\ studies\\ suggest\\ combined\\ modality\\ therapy\\ with\\ preoperative\\ chemoradiotherapy\\ followed\\ by\\ surgery\\ is\\ acceptable\\ management\\ for\\ patients\\ with\\ stage\\ ii\\ and\\ iii\\ cancer\\.\\ optimal\\ treatment\\ for\\ patients\\ with\\ earlier\\ stage\\ disease\\ is\\ less\\ clear\\ and\\ surgery\\ alone\\ is\\ considered\\ reasonable\\.\\ 2\\ \ \(0\)\
\-\ 1\\.\\ feldman\\:\\ sleisenger\\ and\\ fordtran\\â\\€\\™s\\ gastrointestinal\\ and\\ liver\\ disease\\,\\ 7th\\ ed\\.\\,\\ chapter\\ 35\\ \\â\\€\\“\\ esophageal\\ tumors\\,\\ copyright\\ 2002\\ elsevier\ \(0\)\
\-\ 2\\.\\ radiation\\ therapy\\,\\ chemoradiotherapy\\,\\ and\\ neoadjuvant\\ approaches\\ for\\ localized\\ esophageal\\ cancer\\.\\ by\\:\\ forastiere\\,\\ a\\,\\ et\\ al\\.\\ uptodate\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ esophageal\\:\\ 0\\.05723881106516279\ \(0\)\
\-\ chemoradiotherapy\\:\\ 0\\.03758233507450514\ \(0\)\
\-\ esophagus\\:\\ 0\\.030110170049236343\ \(0\)\
\-\ scca\\:\\ 0\\.025054890049670094\ \(0\)\
\-\ cancer\\:\\ 0\\.02280166610685686\ \(0\)\
\-\ samples\\:\\ 0\\.02230392297049086\ \(0\)\
\-\ patients\\:\\ 0\\.021541311032785965\ \(0\)\
\-\ neoadjuvant\\:\\ 0\\.021487967034513892\ \(0\)\
\-\ pull\\:\\ 0\\.02083643880249392\ \(0\)\
\-\ 2001\\.\\:\\ 0\\.02055393433174837\ \(0\)\
\-\ retrocardiac\\:\\ 0\\.019237489175553034\ \(0\)\
\-\ achalasia\\:\\ 0\\.017689034396039038\ \(0\)\
\-\ aids\\:\\ 0\\.017369423770021986\ \(0\)\
\-\ considered\\:\\ 0\\.01679971952408107\ \(0\)\
\-\ \\%\\:\\ 0\\.016179553842094217\ \(0\)\
\-\ endoscopy\\:\\ 0\\.016052978613826648\ \(0\)\
\-\ alone\\:\\ 0\\.015019037928376859\ \(0\)\
\-\ \\:\\:\\ 0\\.014678893714164481\ \(0\)\
\-\ 24jun2004\\:\\ 0\\.014310906532413148\ \(0\)\
\-\ 25june2005\\:\\ 0\\.014310906532413148\ \(0\)\
\-\ ranks\\:\\ 0\\.014310906532413148\ \(0\)\
\-\ esophagorespiratory\\:\\ 0\\.014310906532413148\ \(0\)\
\-\ scaa\\:\\ 0\\.014310906532413148\ \(0\)\
\-\ curable\\:\\ 0\\.014310906532413148\ \(0\)\
\-\ forastiere\\:\\ 0\\.014310906532413148\ \(0\)\
\-\ least\\:\\ 0\\.013905580944198838\ \(0\)\
\-\ squamous\\:\\ 0\\.013573991674470334\ \(0\)\
\-\ dysphagia\\:\\ 0\\.013511552187691478\ \(0\)\
\-\ barium\\:\\ 0\\.01345029087501491\ \(0\)\
\-\ chest\\:\\ 0\\.013277461039334538\ \(0\)\
\-\ are\\:\\ 0\\.013237203096927292\ \(0\)\
\-\ transhiatal\\:\\ 0\\.013185667602932718\ \(0\)\
\-\ esophagography\\:\\ 0\\.013185667602932718\ \(0\)\
\-\ opportunity\\:\\ 0\\.013185667602932718\ \(0\)\
\-\ feldman\\:\\ 0\\.013185667602932718\ \(0\)\
\-\ sleisenger\\:\\ 0\\.013185667602932718\ \(0\)\
\-\ fordtran\\:\\ 0\\.013185667602932718\ \(0\)\
\-\ or\\:\\ 0\\.013006788947580618\ \(0\)\
\-\ 46\\-year\\-old\\:\\ 0\\.012527445024835047\ \(0\)\
\-\ chemoradiation\\:\\ 0\\.012527445024835047\ \(0\)\
\-\ upwards\\:\\ 0\\.012527445024835047\ \(0\)\
\-\ diets\\:\\ 0\\.012527445024835047\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.012486055598670448\ \(0\)\
\-\ generally\\:\\ 0\\.012486055598670448\ \(0\)\
\-\ gastric\\:\\ 0\\.012397097890267479\ \(0\)\
\-\ environmental\\:\\ 0\\.012060428673452285\ \(0\)\
\-\ swallows\\:\\ 0\\.012060428673452285\ \(0\)\
\-\ yields\\:\\ 0\\.012060428673452285\ \(0\)\
\-\ five\\-year\\:\\ 0\\.012060428673452285\ \(0\)\
\-\ 5\\-20\\:\\ 0\\.012060428673452285\ \(0\)\
\-\ copyright\\:\\ 0\\.012060428673452285\ \(0\)\
\-\ indicated\\:\\ 0\\.012004950037499167\ \(0\)\
\-\ stage\\:\\ 0\\.011834527366650477\ \(0\)\
\-\ mediastinal\\:\\ 0\\.011779651357551114\ \(0\)\
\-\ pa\\:\\ 0\\.01160315392502226\ \(0\)\
\-\ films\\:\\ 0\\.01145211491322066\ \(0\)\
\-\ exposures\\:\\ 0\\.011402206095354616\ \(0\)\
\-\ treatable\\:\\ 0\\.011402206095354616\ \(0\)\
\-\ disease\\:\\ 0\\.011337155367010585\ \(0\)\
\-\ considerably\\:\\ 0\\.01115196148524543\ \(0\)\
\-\ flexible\\:\\ 0\\.01115196148524543\ \(0\)\
\-\ metaplasia\\:\\ 0\\.010935189743971854\ \(0\)\
\-\ esophagectomy\\:\\ 0\\.010935189743971854\ \(0\)\
\-\ worldwide\\:\\ 0\\.010935189743971854\ \(0\)\
\-\ approaching\\:\\ 0\\.010935189743971854\ \(0\)\
\-\ amenable\\:\\ 0\\.010935189743971854\ \(0\)\
\-\ rate\\:\\ 0\\.010814030813233257\ \(0\)\
\-\ record\\:\\ 0\\.010743983517256946\ \(0\)\
\-\ habits\\:\\ 0\\.010743983517256946\ \(0\)\
\-\ predisposition\\:\\ 0\\.010572943719111124\ \(0\)\
\-\ implicated\\:\\ 0\\.010572943719111124\ \(0\)\
\-\ ed\\.\\:\\ 0\\.010572943719111124\ \(0\)\
\-\ approaches\\:\\ 0\\.010572943719111124\ \(0\)\
\-\ tumors\\:\\ 0\\.010421157005423705\ \(0\)\
\-\ suboptimal\\:\\ 0\\.01041821940124696\ \(0\)\
\-\ lat\\:\\ 0\\.010276967165874186\ \(0\)\
\-\ presentations\\:\\ 0\\.010276967165874186\ \(0\)\
\-\ chapter\\:\\ 0\\.010276967165874186\ \(0\)\
\-\ uptodate\\:\\ 0\\.010276967165874186\ \(0\)\
\-\ since\\:\\ 0\\.010190794226292911\ \(0\)\
\-\ causative\\:\\ 0\\.010147027705365198\ \(0\)\
\-\ characterization\\:\\ 0\\.010147027705365198\ \(0\)\
\-\ elsevier\\:\\ 0\\.010147027705365198\ \(0\)\
\-\ middle\\:\\ 0\\.010146620031306617\ \(0\)\
\-\ surgery\\:\\ 0\\.010105514923832508\ \(0\)\
\-\ obscuring\\:\\ 0\\.010026722555765\ \(0\)\
\-\ optimal\\:\\ 0\\.010026722555765\ \(0\)\
\-\ acceptable\\:\\ 0\\.009914721141013456\ \(0\)\
\-\ biopsy\\:\\ 0\\.009843159875444029\ \(0\)\
\-\ odynophagia\\:\\ 0\\.009809950814491424\ \(0\)\
\-\ because\\:\\ 0\\.009706228300604053\ \(0\)\
\-\ \\,\\:\\ 0\\.009668216625617405\ \(0\)\
\-\ inlet\\:\\ 0\\.009618744587776517\ \(0\)\
\-\ anorexia\\:\\ 0\\.009618744587776517\ \(0\)\
\-\ 7th\\:\\ 0\\.009618744587776517\ \(0\)\
\-\ obscured\\:\\ 0\\.00953097312467542\ \(0\)\
\-\ worked\\:\\ 0\\.00953097312467542\ \(0\)\
\-\ fistulas\\:\\ 0\\.00953097312467542\ \(0\)\
\-\ locally\\:\\ 0\\.00953097312467542\ \(0\)\
\-\ seek\\:\\ 0\\.009447704789630694\ \(0\)\
\-\ manner\\:\\ 0\\.009447704789630694\ \(0\)\
\-\ high\\-grade\\:\\ 0\\.009447704789630694\ \(0\)\
\-\ obtaining\\:\\ 0\\.00936849997766733\ \(0\)\
\-\ dietary\\:\\ 0\\.00929298047176653\ \(0\)\
\-\ accuracy\\:\\ 0\\.00929298047176653\ \(0\)\
\-\ by\\:\\ 0\\.009239421449642045\ \(0\)\
\-\ luminal\\:\\ 0\\.009220818519541152\ \(0\)\
\-\ ranges\\:\\ 0\\.009151728236393755\ \(0\)\
\-\ reasonable\\:\\ 0\\.009151728236393755\ \(0\)\
\-\ radiation\\:\\ 0\\.009104711849228366\ \(0\)\
\-\ accurate\\:\\ 0\\.009021788775884767\ \(0\)\
\-\ localization\\:\\ 0\\.009021788775884767\ \(0\)\
\-\ biopsies\\:\\ 0\\.008960522009678847\ \(0\)\
\-\ ectasia\\:\\ 0\\.008960522009678847\ \(0\)\
\-\ carcinomas\\:\\ 0\\.00890148362628457\ \(0\)\
\-\ findings\\:\\ 0\\.008857972089886167\ \(0\)\
\-\ basic\\:\\ 0\\.008844517198019519\ \(0\)\
\-\ twice\\:\\ 0\\.008844517198019519\ \(0\)\
\-\ clips\\:\\ 0\\.008844517198019519\ \(0\)\
\-\ obtain\\:\\ 0\\.008789482211533023\ \(0\)\
\-\ infiltrates\\:\\ 0\\.008634757893668861\ \(0\)\
\-\ tracheal\\:\\ 0\\.00853923760142384\ \(0\)\
\-\ allows\\:\\ 0\\.00853923760142384\ \(0\)\
\-\ preoperative\\:\\ 0\\.008493505658296086\ \(0\)\
\-\ epithelial\\:\\ 0\\.0084490268040946\ \(0\)\
\-\ treatment\\:\\ 0\\.008423459218835489\ \(0\)\
\-\ compromise\\:\\ 0\\.008405734195194988\ \(0\)\
\-\ as\\:\\ 0\\.008393360427883948\ \(0\)\
\-\ tobacco\\:\\ 0\\.008363566197787099\ \(0\)\
\-\ air\\-fluid\\:\\ 0\\.008363566197787099\ \(0\)\
\-\ modalities\\:\\ 0\\.008322465860150263\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.008292294609238493\ \(0\)\
\-\ for\\:\\ 0\\.008285319870939944\ \(0\)\
\-\ among\\:\\ 0\\.008243261048186899\ \(0\)\
\-\ primary\\:\\ 0\\.008218780074336678\ \(0\)\
\-\ is\\:\\ 0\\.008215287346530082\ \(0\)\
\-\ panel\\:\\ 0\\.008167741542286099\ \(0\)\
\-\ leiomyoma\\:\\ 0\\.008167741542286099\ \(0\)\
\-\ postoperative\\:\\ 0\\.008060666919247467\ \(0\)\
\-\ s\\:\\ 0\\.007957037880242166\ \(0\)\
\-\ abnormal\\:\\ 0\\.007912637143879582\ \(0\)\
\-\ shadow\\:\\ 0\\.007896549846404335\ \(0\)\
\-\ through\\:\\ 0\\.007879730579288535\ \(0\)\
\-\ altered\\:\\ 0\\.007865627451971391\ \(0\)\
\-\ carcinoma\\:\\ 0\\.007863401526025542\ \(0\)\
\-\ all\\:\\ 0\\.00784715418646523\ \(0\)\
\-\ time\\:\\ 0\\.00783636762090686\ \(0\)\
\-\ hiatal\\:\\ 0\\.007835283080198416\ \(0\)\
\-\ contents\\:\\ 0\\.007835283080198416\ \(0\)\
\-\ duplication\\:\\ 0\\.007805495517425369\ \(0\)\
\-\ deviation\\:\\ 0\\.007747511617097319\ \(0\)\
\-\ configuration\\:\\ 0\\.007747511617097319\ \(0\)\
\-\ combined\\:\\ 0\\.007664243282052594\ \(0\)\
\-\ fifth\\:\\ 0\\.007611013050197089\ \(0\)\
\-\ modality\\:\\ 0\\.007611013050197089\ \(0\)\
\-\ genetic\\:\\ 0\\.00758503847008923\ \(0\)\
\-\ 2002\\:\\ 0\\.00758503847008923\ \(0\)\
\-\ mortality\\:\\ 0\\.007559472955530562\ \(0\)\
\-\ sites\\:\\ 0\\.007559472955530562\ \(0\)\
\-\ gastrointestinal\\:\\ 0\\.007559472955530562\ \(0\)\
\-\ processes\\:\\ 0\\.007509518964188429\ \(0\)\
\-\ cell\\:\\ 0\\.007494288024615215\ \(0\)\
\-\ continue\\:\\ 0\\.007485106825609631\ \(0\)\
\-\ diaphragm\\:\\ 0\\.007461056361672714\ \(0\)\
\-\ survival\\:\\ 0\\.00743735701196305\ \(0\)\
\-\ therapy\\:\\ 0\\.007417664922859134\ \(0\)\
\-\ visualization\\:\\ 0\\.007323787874614169\ \(0\)\
\-\ here\\:\\ 0\\.007238327268306667\ \(0\)\
\-\ experienced\\:\\ 0\\.007197226930669832\ \(0\)\
\-\ always\\:\\ 0\\.0071374639872887995\ \(0\)\
\-\ 75\\:\\ 0\\.007098810336811983\ \(0\)\
\-\ relief\\:\\ 0\\.007079823259274335\ \(0\)\
\-\ auscultation\\:\\ 0\\.00706105569044142\ \(0\)\
\-\ 100\\:\\ 0\\.007006020703954925\ \(0\)\
\-\ alcohol\\:\\ 0\\.006988082658197482\ \(0\)\
\-\ widening\\:\\ 0\\.006988082658197482\ \(0\)\
\-\ annual\\:\\ 0\\.006952790472099419\ \(0\)\
\-\ length\\:\\ 0\\.006952790472099419\ \(0\)\
\-\ values\\:\\ 0\\.006935427989767037\ \(0\)\
\-\ five\\:\\ 0\\.006918249240853828\ \(0\)\
\-\ overall\\:\\ 0\\.006901250377432893\ \(0\)\
\-\ metabolic\\:\\ 0\\.006851296386090761\ \(0\)\
\-\ earlier\\:\\ 0\\.006851296386090761\ \(0\)\
\-\ six\\:\\ 0\\.006818827771307206\ \(0\)\
\-\ physical\\:\\ 0\\.006806835290848177\ \(0\)\
\-\ fistula\\:\\ 0\\.006802833783575044\ \(0\)\
\-\ descending\\:\\ 0\\.006771310916923906\ \(0\)\
\-\ localized\\:\\ 0\\.006755776093845739\ \(0\)\
\-\ almost\\:\\ 0\\.006710044150717985\ \(0\)\
\-\ mediastinum\\:\\ 0\\.006680256587944938\ \(0\)\
\-\ rarely\\:\\ 0\\.006651005767323707\ \(0\)\
\-\ disorders\\:\\ 0\\.006636575657880126\ \(0\)\
\-\ caucasian\\:\\ 0\\.006622272687616888\ \(0\)\
\-\ border\\:\\ 0\\.006608094635719559\ \(0\)\
\-\ 1\\:\\ 0\\.006601708986882166\ \(0\)\
\-\ tissue\\:\\ 0\\.006576042819651279\ \(0\)\
\-\ direct\\:\\ 0\\.006552589173465859\ \(0\)\
\-\ 90\\:\\ 0\\.0065390043525721635\ \(0\)\
\-\ aspiration\\:\\ 0\\.0065390043525721635\ \(0\)\
\-\ dilation\\:\\ 0\\.0065390043525721635\ \(0\)\
\-\ iii\\:\\ 0\\.006512171070183834\ \(0\)\
\-\ current\\:\\ 0\\.006498918942522858\ \(0\)\
\-\ opacity\\:\\ 0\\.006485774120716659\ \(0\)\
\-\ tumor\\:\\ 0\\.006468286693541595\ \(0\)\
\-\ demonstrate\\:\\ 0\\.006384584874457925\ \(0\)\
\-\ 35\\:\\ 0\\.0063842800347079995\ \(0\)\
\-\ those\\:\\ 0\\.00631211808248262\ \(0\)\
\-\ can\\:\\ 0\\.006292929715808668\ \(0\)\
\-\ present\\:\\ 0\\.006266262188089873\ \(0\)\
\-\ lower\\:\\ 0\\.006239811913519035\ \(0\)\
\-\ it\\:\\ 0\\.006236520729003301\ \(0\)\
\-\ factors\\:\\ 0\\.006231793314197928\ \(0\)\
\-\ contrast\\:\\ 0\\.006210310671454239\ \(0\)\
\-\ report\\:\\ 0\\.006209554930499614\ \(0\)\
\-\ in\\:\\ 0\\.00615677771308814\ \(0\)\
\-\ clinically\\:\\ 0\\.006082165944393291\ \(0\)\
\-\ hernia\\:\\ 0\\.006071988001189401\ \(0\)\
\-\ recurrence\\:\\ 0\\.0060518215726203155\ \(0\)\
\-\ using\\:\\ 0\\.00602203400984727\ \(0\)\
\-\ have\\:\\ 0\\.006007915838847701\ \(0\)\
\-\ lateral\\:\\ 0\\.005995675472806982\ \(0\)\
\-\ ii\\:\\ 0\\.0059831488783172486\ \(0\)\
\-\ aorta\\:\\ 0\\.005954584329793905\ \(0\)\
\-\ metastases\\:\\ 0\\.005926513717602248\ \(0\)\
\-\ suggestive\\:\\ 0\\.005926513717602248\ \(0\)\
\-\ screening\\:\\ 0\\.005917263683325238\ \(0\)\
\-\ suggest\\:\\ 0\\.005908066057455632\ \(0\)\
\-\ al\\:\\ 0\\.005880781774474494\ \(0\)\
\-\ \\(\\:\\ 0\\.005863325700031335\ \(0\)\
\-\ and\\/or\\:\\ 0\\.005862843728717051\ \(0\)\
\-\ recurrent\\:\\ 0\\.005853948492086165\ \(0\)\
\-\ s\\/p\\:\\ 0\\.0058188470894673895\ \(0\)\
\-\ rule\\:\\ 0\\.005793010311373397\ \(0\)\
\-\ \\)\\:\\ 0\\.005791702046374229\ \(0\)\
\-\ position\\:\\ 0\\.005776011447952463\ \(0\)\
\-\ specific\\:\\ 0\\.0057342771026436855\ \(0\)\
\-\ levels\\:\\ 0\\.00572605745661033\ \(0\)\
\-\ limits\\:\\ 0\\.005717879219548711\ \(0\)\
\-\ stable\\:\\ 0\\.005717879219548711\ \(0\)\
\-\ same\\:\\ 0\\.005717879219548711\ \(0\)\
\-\ et\\:\\ 0\\.005677594854094614\ \(0\)\
\-\ at\\:\\ 0\\.00563845691314107\ \(0\)\
\-\ aortic\\:\\ 0\\.0056151495930105285\ \(0\)\
\-\ third\\:\\ 0\\.005562413464529217\ \(0\)\
\-\ and\\:\\ 0\\.005552225826156089\ \(0\)\
\-\ persistent\\:\\ 0\\.005533030280042824\ \(0\)\
\-\ aneurysm\\:\\ 0\\.005482855706239128\ \(0\)\
\-\ use\\:\\ 0\\.005482855706239128\ \(0\)\
\-\ also\\:\\ 0\\.0054695441352927\ \(0\)\
\-\ similar\\:\\ 0\\.005441049706072871\ \(0\)\
\-\ cysts\\:\\ 0\\.005434185524076895\ \(0\)\
\-\ stenosis\\:\\ 0\\.005434185524076895\ \(0\)\
\-\ thoracic\\:\\ 0\\.005347495951467942\ \(0\)\
\-\ cough\\:\\ 0\\.005315348829233884\ \(0\)\
\-\ 50\\:\\ 0\\.005277594182863319\ \(0\)\
\-\ management\\:\\ 0\\.005234628966648769\ \(0\)\
\-\ ventricle\\:\\ 0\\.0051986855804844615\ \(0\)\
\-\ studies\\:\\ 0\\.005181007983407727\ \(0\)\
\-\ pt\\:\\ 0\\.005157733367910313\ \(0\)\
\-\ clear\\:\\ 0\\.005129101644718581\ \(0\)\
\-\ dilated\\:\\ 0\\.005040732802908488\ \(0\)\
\-\ malignant\\:\\ 0\\.005014075773343021\ \(0\)\
\-\ they\\:\\ 0\\.004998289166375497\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.004972314586267639\ \(0\)\
\-\ weight\\:\\ 0\\.004972314586267639\ \(0\)\
\-\ obtained\\:\\ 0\\.004931600812895847\ \(0\)\
\-\ obstruction\\:\\ 0\\.004891883195762071\ \(0\)\
\-\ complete\\:\\ 0\\.0048821037889384\ \(0\)\
\-\ that\\:\\ 0\\.004792145222593583\ \(0\)\
\-\ liver\\:\\ 0\\.004782827127975201\ \(0\)\
\-\ less\\:\\ 0\\.0046979545524718875\ \(0\)\
\-\ air\\:\\ 0\\.004693608159986958\ \(0\)\
\-\ type\\:\\ 0\\.004676338033030699\ \(0\)\
\-\ recent\\:\\ 0\\.004663504949415255\ \(0\)\
\-\ extending\\:\\ 0\\.004663504949415255\ \(0\)\
\-\ followed\\:\\ 0\\.004650772518472032\ \(0\)\
\-\ initial\\:\\ 0\\.004596724258570306\ \(0\)\
\-\ out\\:\\ 0\\.004584503046848241\ \(0\)\
\-\ density\\:\\ 0\\.004564336618279155\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.004513047064028802\ \(0\)\
\-\ plain\\:\\ 0\\.004505298234884878\ \(0\)\
\-\ often\\:\\ 0\\.004426093422921514\ \(0\)\
\-\ 2\\.\\:\\ 0\\.004411435295130289\ \(0\)\
\-\ radiographs\\:\\ 0\\.0043932968201333324\ \(0\)\
\-\ such\\:\\ 0\\.004336579204287098\ \(0\)\
\-\ 1\\.\\:\\ 0\\.004333099295937664\ \(0\)\
\-\ show\\:\\ 0\\.0042583700235253675\ \(0\)\
\-\ usually\\:\\ 0\\.004212545866666817\ \(0\)\
\-\ no\\:\\ 0\\.0041904747599211135\ \(0\)\
\-\ to\\:\\ 0\\.0041597543030161\ \(0\)\
\-\ from\\:\\ 0\\.004111804263487702\ \(0\)\
\-\ years\\:\\ 0\\.00407344665100403\ \(0\)\
\-\ loss\\:\\ 0\\.004026727552708506\ \(0\)\
\-\ level\\:\\ 0\\.0039981964734528115\ \(0\)\
\-\ following\\:\\ 0\\.003937139215748618\ \(0\)\
\-\ chronic\\:\\ 0\\.003907450702771104\ \(0\)\
\-\ include\\:\\ 0\\.003891482935114102\ \(0\)\
\-\ ct\\:\\ 0\\.003880856017506633\ \(0\)\
\-\ performed\\:\\ 0\\.0038678219662781157\ \(0\)\
\-\ a\\:\\ 0\\.0038629850826487136\ \(0\)\
\-\ mass\\:\\ 0\\.0038586396329466383\ \(0\)\
\-\ the\\:\\ 0\\.0038153211687688934\ \(0\)\
\-\ been\\:\\ 0\\.0037740176777012846\ \(0\)\
\-\ one\\:\\ 0\\.0037593041936861108\ \(0\)\
\-\ up\\:\\ 0\\.0037302713491139993\ \(0\)\
\-\ due\\:\\ 0\\.003701748624923441\ \(0\)\
\-\ common\\:\\ 0\\.003630303915513632\ \(0\)\
\-\ symptoms\\:\\ 0\\.0034572361637956804\ \(0\)\
\-\ soft\\:\\ 0\\.0033781278636258933\ \(0\)\
\-\ most\\:\\ 0\\.0032026544508572665\ \(0\)\
\-\ posterior\\:\\ 0\\.003197465176465014\ \(0\)\
\-\ other\\:\\ 0\\.003197465176465014\ \(0\)\
\-\ diagnosis\\:\\ 0\\.003185420991526656\ \(0\)\
\-\ well\\:\\ 0\\.003138118430143914\ \(0\)\
\-\ exam\\:\\ 0\\.0030474576947232762\ \(0\)\
\-\ may\\:\\ 0\\.0030427408586008505\ \(0\)\
\-\ of\\:\\ 0\\.0030260727479997\ \(0\)\
\-\ had\\:\\ 0\\.0029932626935725783\ \(0\)\
\-\ 2\\:\\ 0\\.0029871826242054323\ \(0\)\
\-\ but\\:\\ 0\\.002958609254924574\ \(0\)\
\-\ surgical\\:\\ 0\\.002915944432226386\ \(0\)\
\-\ images\\:\\ 0\\.0026611426817359646\ \(0\)\
\-\ with\\:\\ 0\\.0026591858202247667\ \(0\)\
\-\ within\\:\\ 0\\.002646317221405977\ \(0\)\
\-\ has\\:\\ 0\\.002605032419633568\ \(0\)\
\-\ male\\:\\ 0\\.0025084505485186252\ \(0\)\
\-\ on\\:\\ 0\\.0023502954946929486\ \(0\)\
\-\ normal\\:\\ 0\\.002174695543180359\ \(0\)\
\-\ be\\:\\ 0\\.0021392154599739113\ \(0\)\
\-\ there\\:\\ 0\\.002064473305949657\ \(0\)\
\-\ an\\:\\ 0\\.0019182871173453408\ \(0\)\
\-\ history\\:\\ 0\\.0019159326910829278\ \(0\)\
\-\ \\.\\:\\ 0\\.00167124439419325\ \(0\)\
\-\ year\\:\\ 0\\.0015521189436248617\ \(0\)\
\-\ left\\:\\ 0\\.0015521189436248617\ \(0\)\
\-\ patient\\:\\ 0\\.0013905713164227079\ \(0\)\
